Exercise During Chemotherapy for Patients With Hematological Malignancies

Charite University, Berlin, Germany60 enrolled

Overview

The trial will evaluate the effects of aerobic exercise in patients undergoing chemotherapy for the treatment of a hematological neoplastic disease.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Masking

SINGLE

Enrollment

Conditions

Hematological Diseases Hematological Malignancies

Interventions

Aerobic exerciseOTHER

The patients will carry out an aerobic exercise program consisting of walking on a treadmill for 30 minutes at an intensity of 80% of the maximum heart rate. The training will be carried out three times a week.

Fatigue counselingBEHAVIORAL

The patients will receive a counseling regarding the causes of fatigue, how to cope with this symptom, and general recommendations about exercise. However, they will not participate at a structured exercise program.

Eligibility

Sex: ALLMin age: 18 YearsMax age: 70 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Hematological malignant disease * Current chemotherapy * Understanding of written German Exclusion Criteria: * Cardiorespiratory, metabolical, osteoarticular or immunological disorders which can be aggravated by exercise * Pathological stress-ECG at recruitment

Locations (1)

Section Sports Medicine, Charité Universitätsmedizin Berlin, Hindenburgdamm 30

Berlin, State of Berlin, Germany

RECRUITING

Outcomes

Primary Outcomes

Fatigue

Time frame: At recruitment and after 12 weeks

Secondary Outcomes

Complications

Time frame: At recruitment and after 12 weeks

Physical performance

Time frame: At recruitment and after 12 weeks

Central Contacts

Fernando Dimeo, MD

CONTACT

+493084452098 fernando.dimeo@charite.de

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.